You Position: Home > Paper

Current study status of radiotherapy modality on early stage nasal NK/T cell lymphoma

( views:221, downloads:40 )
Author:
No author available
Journal Title:
Journal of Leukemia & Lymphoma
Issue:
10
DOI:
10.3760/cma.j.issn.1009-9921.2012.10.021
Key Word:
淋巴瘤,非霍奇金;鼻腔;放疗靶区;放疗剂量;颈部预防照射;Lymphoma,Non-Hodgkin;Nasal Cavity;Radiation target;Radiation dose;Preventive neck radiation

Abstract: Nasal NK/T cell lymphoma is a rare and distinct type of extranodal Non-Hodgkin' s lymphoma. Current study has proved that Radiotherapy is the most effective treatment method in the early stage nasal NK/T cell lymphoma, but there is no universal standard for concrete radiotherapy modality, such as the radiation target, the radiation dose and preventive neck radiation. Most studies have proved that radiotherapy of extended field and higher dose achieved good effect in early stage nasal NK/T cell lymphoma.And the studies also do not suggested preventive neck radiation in local stage patients, but it need further study in the extensive stage patients.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn